Schwarz Pharma’s Neupro Patch Gets FDA Nod For Early Parkinson’s Disease
Executive Summary
Schwarz Pharma will launch its newly approved Parkinson's patch Neupro (rotigotine) within weeks using a "focused" promotional plan
You may also be interested in...
UCB’s Neupro Manufacturing Problems Hold Up Approval For Advanced Parkinson’s Disease
UCB must resolve the issue of drug crystal formation in the Neupro patch before it can be approved for two supplemental indications.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011